IDSA launches coalition for antimicrobial resistance

The Infectious Diseases Society of America launched a coalition of stakeholders to work with government leaders to inform federal policy and develop a coordinated national plan to combat antimicrobial resistance. Over 75 organizations have joined the group, the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR). Participating organizations include IDSA, BIO and infectious disease companies Achaogen Inc. (NASDAQ:AKAO), Cempra Inc. (NASDAQ:CEMP), Cubist Pharmaceuticals Inc. (NASDAQ:CBST) and Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH). S-FAR is set to hold its inaugural meeting on Oct. 9. ...